Kathryn Glass, the co-head of Federated Hermes’ high-yield fixed-income group, epitomizes the unexpected trajectory of careers in finance. Initially, her path seemed predetermined in the realm of Japanese language and literature. Pursuing a bachelor’s degree at the University of Pittsburgh and a master’s at Cornell, Glass’s early ambitions revolved around the nuanced world of literature.
0 Comments
As the cinematic landscape evolves, Hollywood’s titans are responding to the ever-growing appetite for immersive experiences. A prime illustration of this trend is AMC Entertainment’s ambitious plan to amplify its premium screen presence. The cinema giant has announced a significant rise in Dolby Cinema theaters, pledging to open 40 new locations by 2027. This move
0 Comments
As members of the United States armed forces transition back into civilian life, they often find themselves navigating a complex landscape of financial opportunities and challenges. With unique perks and tax benefits available exclusively to military personnel, leveraging these advantages can significantly influence their financial trajectory. A closer examination reveals a wealth of strategies that
0 Comments
For years, investment strategies on Wall Street have largely catered to the wealthy elite, leaving the average American to navigate a sea of traditional mutual funds and basic savings accounts. However, the remarkable changes sweeping the financial landscape point to an unprecedented shift. As financial giants like JPMorgan Chase and BlackRock extend coveted investment strategies,
0 Comments
The tumultuous political landscape of recent years has reverberated through the stock market, with tariffs instituted under the Trump administration raising alarms about potential recession risks. As the market continues to experience volatility, the opportunities to invest wisely may not be as elusive as they seem. Here, we explore three compelling stocks that have surfaced
0 Comments
In a significant development for the diabetes and cardiovascular disease community, Novo Nordisk’s diabetes medication Rybelsus has demonstrated promising cardiovascular benefits in a late-stage clinical trial presented at the American College of Cardiology’s Annual Scientific Session in Chicago. This remarkable finding highlights the urgent need for innovative treatment options, especially for patients grappling with both
0 Comments
The expiration of a crucial patent held by Vanguard is poised to create significant ripples in the landscape of the exchange-traded fund (ETF) industry. As of 2023, this previously proprietary advantage will be available for competitors to exploit, igniting both excitement and anxiety among investors and financial institutions alike. This shift may well democratize access
0 Comments